DAWN stock gains on a higher revenue outlook

Published on 09/18/2026 at 11:01 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Day One Biopharmaceuticals stock rose after etnet reported a higher full-year revenue outlook on September 18, 2026. The shares are listed on Nasdaq and the latest quote showed a $1.44 billion market value.

DAWN, US23933J1034, Illustration mit AI erstellt.

Day One Biopharmaceuticals stock (US23933J1034) gained attention on September 18, 2026, after Hong Kong portal etnet highlighted a higher full-year revenue outlook for a Chinese biotech peer and cited Morgan Stanley's unchanged target at HKD 57.00. For DAWN, the latest market snapshot puts the Nasdaq-listed stock at USD 4.31, with a market capitalization of USD 387.9 million and volume of 1,248,513 shares as of September 17, 2026.

Valuation stays compressed

The stock's 52-week range runs from USD 3.92 to USD 17.50, which places the latest quote close to the lower end of the band. That gap matters for investors because it frames the market's current caution much more clearly than a one-day move alone.

Day One Biopharmaceuticals reported revenue of USD 22.5 million in the second quarter of 2026, up from USD 18.7 million a year earlier, and posted a net loss of USD 38.4 million for the same period. The company said gross margin was 82.6 percent in Q2 2026, which shows that the commercial mix is still a central part of the story.

Quarterly figures set the tone

For the first half of 2026, revenue reached USD 41.9 million and the net loss was USD 74.1 million, while the company also guided to full-year 2026 revenue of USD 92 million to USD 98 million. That range gives the stock a measurable benchmark for the rest of the year, especially after Q2 revenue of USD 22.5 million.

The company also had cash, cash equivalents and marketable securities of USD 329.4 million at June 30, 2026. For a small-cap biotech, that balance sheet figure is one of the clearest numbers investors can use to judge runway against the current loss profile.

Nasdaq price frame

DAWN stock last traded at USD 4.31 on September 17, 2026, after closing at USD 4.28, with the stock up 0.70 percent on the session. The market capitalization of USD 387.9 million and the 52-week low of USD 3.92 show how far the shares still sit from the year high of USD 17.50.